Table 2.
ALS (n = 12) | HC (n = 12) | p-Value | |
---|---|---|---|
Right hippocampus | |||
tNAA | 8.71 ± 1.29 | 6.25 ± 1.34 | <0.001 |
tCho | 2.33 ± 0.66 | 1.95 ± 0.44 | 0.044 |
tCr | 8.58 ± 1.34 | 8.85 ± 2.58 | 0.886 |
Glu | 9.14 ± 3.20 | 5.86 ± 3.50 | 0.028 |
Ins | 11.32 ± 2.37 | 10.01 ± 3.89 | 0.433 |
tNAA/tCho | 4.04 ± 1.32 | 3.36 ± 0.97 | 0.311 |
tNAA/tCr | 1.02 ± 0.12 | 0.76 ± 0.25 | 0.001 |
tCho/tCr | 0.27 ± 0.06 | 0.23 ± 0.05 | 0.033 |
Glu/tNAA | 1.07 ± 0.40 | 0.88 ± 0.47 | 0.371 |
Glu/tCho | 4.49 ± 2.52 | 3.11 ± 1.90 | 0.175 |
Glu/tCr | 1.09 ± 0.42 | 0.69 ± 0.40 | 0.051 |
Ins/tNAA | 1.35 ± 0.49 | 1.65 ± 0.65 | 0.178 |
Ins/tCho | 5.91 ± 4.71 | 5.57 ± 3.01 | 0.799 |
Ins/tCr | 1.37 ± 0.45 | 1.24 ± 0.58 | 0.799 |
Left hippocampus | |||
tNAA | 11.45 ± 4.31 | 5.57 ± 2.22 | <0.001 |
tCho | 3.00 ±1.50 | 1.82 ± 0.78 | 0.004 |
tCr | 9.34 ± 4.03 | 7.35 ± 1.82 | 0.066 |
Glu | 11.26 ± 9.24 | 5.82 ± 2.59 | 0.065 |
Ins | 12.34 ± 4.04 | 8.52 ± 1.96 | 0.013 |
tNAA/tCho | 5.03 ± 4.12 | 3.29 ± 1.31 | 0.284 |
tNAA/tCr | 1.27 ± 0.17 | 0.78 ± 0.31 | <0.001 |
tCho/tCr | 0.31 ± 0.08 | 0.24 ± 0.07 | 0.020 |
Glu/tNAA | 0.90 ± 0.54 | 1.27 ± 0.88 | 0.431 |
Glu/tCho | 3.35 ± 2.15 | 3.74 ± 1.94 | 0.578 |
Glu/tCr | 1.09 ± 0.66 | 0.83 ± 0.37 | 0.214 |
Ins/tNAA | 1.37 ± 1.21 | 2.10 ± 2.00 | 0.075 |
Ins/tCho | 11.26 ± 24.98 | 5.66 ± 2.84 | 0.342 |
Ins/tCr | 1.87 ± 2.06 | 1.23 ± 0.39 | 0.514 |
Note. Metabolites’ absolute concentrations are presented in mM. Bold p-values denote significant differences between ALS and HC groups based on Mann-Whitney U test (Monte Carlo method, sampling n = 30,000). ALS = healthy controls; HC = healthy controls; tNAA = total N-acetyl-asparate; tCho = total Choline; tCr = total Creatine; Glu = glutamate; Ins = inositol; mM = millimolar.